Literature DB >> 1734660

Efficacy and safety of a new selective class III antiarrhythmic agent dofetilide in paroxysmal atrial fibrillation or atrial flutter.

M J Suttorp1, P E Polak, A van 't Hof, H S Rasmussen, P H Dunselman, J H Kingma.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1992        PMID： 1734660     DOI： 10.1016/0002-9149(92)90247-v

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN： 0002-9149            Impact factor:   2.778


× No keyword cloud information.
  12 in total

Review 1.  Dofetilide: a review of its use in atrial fibrillation and atrial flutter.

Authors:  K J McClellan; A Markham
Journal:  Drugs       Date:  1999-12       Impact factor: 9.546

2.  The use of clinical irrelevance criteria in covariate model building with application to dofetilide pharmacokinetic data.

Authors:  Karin Tunblad; Lars Lindbom; Lynn McFadyen; E Niclas Jonsson; Scott Marshall; Mats O Karlsson
Journal:  J Pharmacokinet Pharmacodyn       Date:  2008-11-15       Impact factor: 2.745

3.  The pharmacokinetics and pharmacodynamics of oral dofetilide after twice daily and three times daily dosing.

Authors:  M J Allen; D J Nichols; S D Oliver
Journal:  Br J Clin Pharmacol       Date:  2000-09       Impact factor: 4.335

Review 4.  Pharmacological cardioversion of atrial fibrillation: current management and treatment options.

Authors:  Giuseppe Boriani; Igor Diemberger; Mauro Biffi; Cristian Martignani; Angelo Branzi
Journal:  Drugs       Date:  2004       Impact factor: 9.546

5.  Superiority of ibutilide (a new class III agent) over DL-sotalol in converting atrial flutter and atrial fibrillation. The Ibutilide/Sotalol Comparator Study Group.

Authors:  M A Vos; S R Golitsyn; K Stangl; M Y Ruda; L V Van Wijk; J D Harry; K T Perry; P Touboul; G Steinbeck; H J Wellens
Journal:  Heart       Date:  1998-06       Impact factor: 5.994

6.  Effect of cimetidine and ranitidine on pharmacokinetics and pharmacodynamics of a single dose of dofetilide.

Authors:  S Abel; D J Nichols; C J Brearley; M D Eve
Journal:  Br J Clin Pharmacol       Date:  2000-01       Impact factor: 4.335

7.  Effects of intravenous dofetilide on induction of atrioventricular re-entrant tachycardia.

Authors:  S M Cobbe; R W Campbell; A J Camm; A W Nathan; E Rowland; P E Bloch-Thomsen; M Møller; L Jordaens
Journal:  Heart       Date:  2001-11       Impact factor: 5.994

Review 8.  Is there a future for antiarrhythmic drug therapy?

Authors:  P G Guerra; M Talajic; D Roy; M Dubuc; B Thibault; S Nattel
Journal:  Drugs       Date:  1998-11       Impact factor: 9.546

Review 9.  Drug-induced torsade de pointes. Incidence, management and prevention.

Authors:  T S Faber; M Zehender; H Just
Journal:  Drug Saf       Date:  1994-12       Impact factor: 5.606

Review 10.  Clinical pharmacology of antiarrhythmic drugs.

Authors:  A Capucci; D Aschieri; G Q Villani
Journal:  Drugs Aging       Date:  1998-07       Impact factor: 3.923
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.